Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 12.01% is 194% above its 5-year average of -12.72%, near the high end of its 5-year range (-41.09%–12.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 1650.80% above its 12-month average of 0.69%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 12.01%.
RETURN ON EQUITY (ROE)
12.01%
RETURN ON EQUITY (ROE) AVG TTM
0.69%
RETURN ON EQUITY (ROE) AVG 3Y
-10.46%
RETURN ON EQUITY (ROE) AVG 5Y
-12.72%
RETURN ON EQUITY (ROE) AVG 10Y
-13.59%
RETURN ON EQUITY (ROE) AVG 15Y
-17.16%
RETURN ON EQUITY (ROE) AVG 20Y
-18.74%
CURRENT VS TTM AVG
+1650.80%
CURRENT VS 3Y AVG
+214.86%
CURRENT VS 5Y AVG
+194.40%
CURRENT VS 10Y AVG
+188.37%
CURRENT VS 15Y AVG
+170.00%
CURRENT VS 20Y AVG
+164.08%
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
+131.89%
vs the sector median at left
BioLife Solutions, Inc.
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
0.69%
3Y Avg
-10.46%
5Y Avg
-12.72%
Market Cap
$1.87B
Return on Equity (ROE)
-40.09%
TTM Avg
4.56%
3Y Avg
-13.84%
5Y Avg
-2.18%
Market Cap
$1.83B
Return on Equity (ROE)
4.88%
TTM Avg
4.47%
3Y Avg
6.79%
5Y Avg
5.89%
Market Cap
$1.95B
Return on Equity (ROE)
-49.19%
TTM Avg
-59.18%
3Y Avg
-54.84%
5Y Avg
-44.72%
Market Cap
$1.96B
Return on Equity (ROE)
-179.99%
TTM Avg
-188.10%
3Y Avg
28.98%
5Y Avg
-2.67%
Market Cap
$1.97B
Return on Equity (ROE)
-8.14%
TTM Avg
-6.28%
3Y Avg
-6.47%
5Y Avg
-2.03%
Market Cap
$1.78B
Return on Equity (ROE)
N/A
TTM Avg
36.48%
3Y Avg
36.48%
5Y Avg
36.48%
Market Cap
$1.78B
Return on Equity (ROE)
-54.96%
TTM Avg
-60.50%
3Y Avg
-51.30%
5Y Avg
-42.73%
Market Cap
$2.00B
Return on Equity (ROE)
-13.09%
TTM Avg
-10.89%
3Y Avg
-18.29%
5Y Avg
-19.41%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | 12.01% | 0.69% | -10.46% | -12.72% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -40.09% | 4.56% | -13.84% | -2.18% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 4.88% | 4.47% | 6.79% | 5.89% |
| Absci Corporation (ABSI)vs › | $1.95B | -49.19% | -59.18% | -54.84% | -44.72% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -179.99% | -188.10% | 28.98% | -2.67% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -8.14% | -6.28% | -6.47% | -2.03% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | N/A | 36.48% | 36.48% | 36.48% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -54.96% | -60.50% | -51.30% | -42.73% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -13.09% | -10.89% | -18.29% | -19.41% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -16.25% | -99.56% | -48.75% | -32.00% |
ROE
12.0%
ROA
11.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 12.01% |
| 2026-03-31 | -2.82% |
| 2025-12-31 | -3.26% |
| 2025-09-30 | -0.91% |
| 2025-06-30 | -1.59% |
| 2025-03-31 | -2.95% |
| 2024-12-31 | -5.78% |
| 2024-09-30 | -14.14% |
| 2024-06-30 | -22.85% |
| 2024-03-31 | -18.88% |
| 2023-12-31 | -19.67% |
| 2023-09-30 | -31.10% |
| 2023-06-30 | -23.99% |
| 2023-03-31 | -41.09% |
| 2022-12-31 | -38.67% |
| 2022-09-30 | -25.74% |
| 2022-06-30 | -22.97% |
| 2022-03-31 | -2.91% |
| 2021-12-31 | -1.60% |
| 2021-09-30 | 0.96% |
| 2021-06-30 | 0.77% |
| 2021-03-31 | -9.94% |
| 2020-12-31 | 1.30% |
| 2020-09-30 | -3.98% |
| 2020-06-30 | 3.74% |
| 2020-03-31 | 36.32% |
| 2019-12-31 | -38.84% |
| 2019-09-30 | -4.87% |
| 2019-06-30 | -27.63% |
| 2019-03-31 | -35.83% |
| 2018-12-31 | 22.32% |
| 2018-09-30 | 4.13% |
| 2018-06-30 | 1.35% |
| 2018-03-31 | -15.68% |
| 2017-12-31 | -24.92% |
| 2017-09-30 | -73.20% |
| 2017-06-30 | -86.96% |
| 2017-03-31 | -232.53% |
| 2016-12-31 | -217.18% |
| 2016-09-30 | -75.81% |
| 2016-06-30 | -69.93% |
| 2016-03-31 | -59.24% |
| 2015-12-31 | -49.53% |
| 2014-09-30 | -22.02% |
| 2014-06-30 | -16.70% |
| 2014-03-31 | -11.62% |
| 2006-12-31 | -629.70% |
| 2006-09-30 | -725.24% |
| 2006-06-30 | -191.30% |
| 2005-09-30 | -303.08% |
| 2005-06-30 | -206.84% |
| 2005-03-31 | -143.96% |
| 2004-12-31 | -121.24% |
| 2004-09-30 | -74.67% |
| 2004-06-30 | -110.14% |
| 2004-03-31 | -110.49% |
| 2003-12-31 | -95.06% |
